No HECS for Biotechs

In today’s Age, I respond to Mike Vitalie’s suggestion that there be a HECS scheme for biotechnology firms in Victoria. I argue that while the intentions may be good, it may be ‘solving the wrong problem’ when it comes to VC funding.

You can read the Age article here. It basically expands on my blog from last week on the same issue.